Utilities for Complications Associated with Type 2 Diabetes: A Review of the Literature

被引:0
作者
Valentine, William J. [1 ]
Norrbacka, Kirsi [2 ]
Boye, Kristina S. [3 ]
机构
[1] Ossian Hlth Econ & Commun GmbH, Baumleingasse 20, CH-4051 Basel, Switzerland
[2] Eli Lilly Finland, Helsinki, Finland
[3] Eli Lilly & Co, Indianapolis, IN USA
关键词
Diabetes-related complications; Health state utility; Quality of life; Type; 2; diabetes; Utilities; BODY-MASS INDEX; PERIPHERAL NEUROPATHY; HEALTH UTILITIES; US PATIENTS; LIFE; HYPOGLYCEMIA; INDIVIDUALS; SEVERITY; MELLITUS; OUTCOMES;
D O I
10.1007/s12325-024-02878-x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Introduction Utility values are used in health economic modeling analyses of type 2 diabetes (T2D) to quantify the effect of acute and long-term complications on quality of life (QoL). For accurate modeling projections, it is important that the utility values used are up to date, accurate and representative of the simulated model cohort.Methods A literature review was performed to identify utility values for health states representing acute and chronic T2D-related complications including cardiovascular complications, stroke, renal disease, ophthalmic complications, neuropathy, diabetic foot, amputation and hypoglycemia. Searches were performed using the PubMed, Embase and Cochrane Library databases and limited to articles published since 2010. Supplementary searches were performed to identify data published at congresses in 2019-2023.Results A total of 54 articles were identified that reported utility values for T2D-related complications. The most frequently used elicitation method/instrument was the EQ-5D (n = 42 studies) followed by the Short Form-6 dimensions (n = 6), time tradeoff (n = 5), the Health Utilities Index Mark 2 or Mark 3 (n = 2), 15D (n = 1), visual analog scale (n = 1) and standard gamble (n = 1). Stroke and amputation were consistently associated with the largest decrements in QoL. There is a lack of published data that distinguishes between severity of several complications including renal disease, retinopathy and neuropathy.Conclusions Diabetes-related complications can have a profound impact on QoL; therefore, it is important that these are captured accurately and appropriately in health economic models. Recently published utility values for diabetes-related complications that can be used to inform health economic models are summarized here.
引用
收藏
页码:2655 / 2681
页数:27
相关论文
共 69 条
[1]   Sensitivity and Responsiveness of Health Utility Indices (HUI2 and HUI3) Among Type 2 Diabetes Patients [J].
Adibe, Maxwell Ogochukwu ;
Aguwa, Cletus Nze .
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2013, 12 (05) :835-842
[2]   Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes [J].
Al Sayah, Fatima ;
Qiu, Weiyu ;
Xie, Feng ;
Johnson, Jeffrey A. .
QUALITY OF LIFE RESEARCH, 2017, 26 (08) :2057-2066
[3]  
[Anonymous], 2015, METHODS HLTH EC EVAL
[4]   Comparison of direct and indirect methods of estimating health state utilities for resource allocation: review and empirical analysis [J].
Arnold, David ;
Girling, Alan ;
Stevens, Andrew ;
Lilford, Richard .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 339 :385-388
[5]   Review of Utility Values for Economic Modeling in Type 2 Diabetes [J].
Beaudet, Amelie ;
Clegg, John ;
Thuresson, Per-Olof ;
Lloyd, Adam ;
McEwan, Phil .
VALUE IN HEALTH, 2014, 17 (04) :462-470
[6]   Differences in utility elicitation methods in cardiovascular disease: a systematic review [J].
Betts, Marissa Blieden ;
Gandra, Shravanthi R. ;
Cheng, Lung-I ;
Szatkowski, Anna ;
Toth, Peter P. .
JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (01) :74-84
[7]   Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report [J].
Brazier, John ;
Ara, Roberta ;
Azzabi, Ismail ;
Busschbach, Jan ;
Chevrou-Severac, Helene ;
Crawford, Bruce ;
Cruz, Luciane ;
Karnon, John ;
Lloyd, Andrew ;
Paisley, Suzy ;
Pickard, A. Simon .
VALUE IN HEALTH, 2019, 22 (03) :267-275
[8]   Health-related quality-of-life implications of cardiovascular events in individuals with type 2 diabetes mellitus: A subanalysis from the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR)-TIMI 53 trial [J].
Briggs, Andrew H. ;
Bhatt, Deepak L. ;
Scirica, Benjamin M. ;
Raz, Itamar ;
Johnston, Karissa M. ;
Szabo, Shelagh M. ;
Bergenheim, Klas ;
Mukherjee, Jayanti ;
Hirshberg, Boaz ;
Mosenzon, Ofri .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 130 :24-33
[9]   EQ-5D: a plea for accurate nomenclature [J].
Brooks, Richard ;
Boye, Kristina S. ;
Slaap, Bernhard .
JOURNAL OF PATIENT-REPORTED OUTCOMES, 2020, 4 (01)
[10]  
Butt M, 2018, Asian Journal of Pharmaceutical and Clinical Research, V11, P93, DOI [10.22159/ajpcr.2018.v11i1.19120, 10.22159/ajpcr.2018.v11i1.19120, DOI 10.22159/AJPCR.2018.V11I1.19120]